- Home
- UTG vs BHC Comparison
UTG vs BHC Comparison
Compare UTG & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UTG
- BHC
- Stock Information
- Founded
- UTG 2003
- BHC N/A
- Country
- UTG United States
- BHC Canada
- Employees
- UTG N/A
- BHC N/A
- Industry
- UTG Investment Managers
- BHC Biotechnology: Pharmaceutical Preparations
- Sector
- UTG Finance
- BHC Health Care
- Exchange
- UTG Nasdaq
- BHC Nasdaq
- Market Cap
- UTG 2.8B
- BHC 2.0B
- IPO Year
- UTG N/A
- BHC N/A
- Fundamental
- Price
- UTG $33.56
- BHC $4.71
- Analyst Decision
- UTG
- BHC Hold
- Analyst Count
- UTG 0
- BHC 5
- Target Price
- UTG N/A
- BHC $7.20
- AVG Volume (30 Days)
- UTG 317.8K
- BHC 2.7M
- Earning Date
- UTG 01-01-0001
- BHC 04-30-2025
- Dividend Yield
- UTG 7.28%
- BHC N/A
- EPS Growth
- UTG N/A
- BHC N/A
- EPS
- UTG 9.86
- BHC N/A
- Revenue
- UTG $96,107,593.00
- BHC $9,731,000,000.00
- Revenue This Year
- UTG N/A
- BHC $4.92
- Revenue Next Year
- UTG N/A
- BHC $2.36
- P/E Ratio
- UTG $3.20
- BHC N/A
- Revenue Growth
- UTG 8.35
- BHC 8.53
- 52 Week Low
- UTG $25.26
- BHC $3.96
- 52 Week High
- UTG $35.29
- BHC $9.85
- Technical
- Relative Strength Index (RSI)
- UTG 64.84
- BHC 36.86
- Support Level
- UTG $32.86
- BHC $4.63
- Resistance Level
- UTG $34.05
- BHC $5.60
- Average True Range (ATR)
- UTG 0.53
- BHC 0.27
- MACD
- UTG 0.24
- BHC 0.01
- Stochastic Oscillator
- UTG 85.78
- BHC 11.88
About UTG Reaves Utility Income Fund of Beneficial Interest
Reaves Utility Income Fund is a closed-end management investment company. The company's investment objective is to provide a high level of after-tax income and total return consisting of tax-advantaged dividend income and capital appreciation. It invests a portion of its total assets in securities of utility companies, which may include companies in the electric, gas, water, telecommunications sectors, as well as other companies engaged in other infrastructure operations.
About BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.